Home Imprint Sitemap Profile News & Events Management Contact us News & Events 2014 January 2014 Heidelberg Pharma is very pleased to invite you to a Taconic Webinar on »Human TNF-α Transgenic Mouse Model of Spontaneous Arthritis« presented by our CSO, Prof. Dr. Andreas Pahl. Audiorecording and presentation slides are available at Taconic’s website or at this website. 2013 September 2013 Heidelberg Pharma, a wholly owned subsidiary of WILEX AG, signs license agreement for the development of Antibody Targeted Amanitin Conjugates (ATACs) with Roche [...] May 2013 Heidelberg Pharma has relaunched its website Heidelberg Pharma to provide visitors with a clear understanding of the pre-clincal services offered by Heidelberg Pharma. The new website includes more in-depth information about Heidelberg Pharma’s ADC technology. Print This Page | Email This Page About us Profile News & Events Management History Contact us Google+ Services General Cancer Inflammation DMPK Molecular biology Quality assurance ADC Technology Technology References Bibliography Investor Investor contact Contact Business Development Service Jobs Directions Unsubscribe from our Service-Newsletter